EnglishA head-to-head study of representative examples of N-hydroxyindole-2-carboxylates (NHI) and malonic derivatives (Mal) as LDH-A inhibitors was conducted, comparing enzyme inhibition potency, cellular uptake, reduction of lactate production in cancer cells and anti-proliferative activity. Among the compounds tested, methyl 1-hydroxy-6-phenyl-4-(trifluoromethyl)-1H-indole-2-carboxylate (2, NHI-2), a methyl ester belonging to the NHI class, displayed optimal properties in the cell-based assays, proving to be an efficient anti-glycolytic agent against cancer cells.
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11568/226342| Autori: | |
| Autori: | Carlotta Granchi; Emilia C. Calvaresi; Tiziano Tuccinardi; Ilaria Paterni; Marco Macchia; Adriano Martinelli; Paul J. Hergenrother; Filippo Minutolo |
| Titolo: | Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds |
| Anno del prodotto: | 2013 |
| Digital Object Identifier (DOI): | 10.1039/C3OB40870A |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Copyright © 2017